维普中文期刊产品整合服务
19篇 您的检索式:作者名="Bruno Federica"
    题名 作者 年代 出处 被引量
1CYP450- and COMT-Derived Estradiol Metabolites Inhibit Activity of Human Coronary Artery SMCs显示文摘Raghvendra K. Dubey Delbert G. Gillespie Lefteris C. Zacharia Federica Barchiesi Bruno Imthurn Edwin K. Jackson 2003 (3, P)0,,:1
2Early HER2 dysregulation in gastric and oesophageal carcinogenesis显示文摘Matteo Fassan Luca Mastracci Federica Grillo Vittorina Zagonel Sara Bruno Giorgio Battaglia Francesca Pitto Donato Nitti Tiziana Celiento Giovanni Zaninotto Roberto Fiocca Massimo Rugge 2012Histopathology2012,,5:1
3Relationship between thrombopoietin serum levels and liver function in patients with chronic liver disease related to hepatitis C virus infection显示文摘Edoardo Giannini Federica Botta Paolo Borro Federica Malfatti Alessandra Fumagalli Emanuela Testa Elena Podestà Bruno Chiarbonello Simone Polegato Mario Mamone Roberto Testa 2003The American Journal of Gastroenterology2003,,11:1
4Serum thrombopoietin levels are linked to liver function in untreated patients with hepatitis C virus-related chronic hepatitis显示文摘Edoardo Giannini Paolo Borro Federica Botta Alessandra Fumagalli Federica Malfatti Elena Podestà Paola Romagnoli Emanuela Testa Bruno Chiarbonello Simone Polegato Mario Mamone Roberto Testa 2002Journal of Hepatology2002,,5:1
5Chemical analysis, antioxidant, antiinflammatory and anticholinesterase activities of Origanum ehrenbergii Boiss and Origanum syriacum L. essential oils显示文摘Monica R. Loizzo Federica Menichini Filomena Conforti Rosa Tundis Marco Bonesi Antoine M. Saab Giancarlo A. Statti Bruno de Cindio Peter J Houghton Francesco Menichini Natale Giuseppe Frega 2009Food Chemistry2009,,1:1
6Determination of Surfactants and Some of Their Metabolites in Untreated and Anaerobically Digested Sewage Sludge by Subcritical Water Extraction Followed by Liquid Chromatography-Mass Spectrometry显示文摘Bruno Federica Curini Roberta Di Corcia Antonio 2002Environmental Science and Technology2002,36,19:1
7Treatment of Experimental Injury of Anal Sphincters with Primary Surgical Repair and Injection of Bone Marrow-Derived Mesenchymal Stem Cells显示文摘Bruno Lorenzi M.D. Federica Pessina Ph.D. Paola Lorenzoni Ph.D. Serena Urbani B.S. Remo Vernillo M.D. Giampietro Sgaragli M.D. Renato Gerli M.D. Benedetta Mazzanti Ph.D. Alberto Bosi M.D. Riccardo Saccardi M.D. Marco Lorenzi M.D 2008Diseases of the Colon & Rectum2008,,4:1
8Role of carcinoembryonic antigen, magnetic resonance imaging, and positron emission tomography-computed tomography in the evaluation of patients with suspected local recurrence of colorectal cancer显示文摘Federica Fiocchi Valentina Iotti Guido Ligabue Norma Malavasi Gabriele Luppi Bruno Bagni Pietro Torricelli 2011Clinical Imaging2011,,4:1
9In vitro inhibitory activities of plants used in Lebanon traditional medicine against angiotensin converting enzyme (ACE) and digestive enzymes related to diabetes显示文摘Monica R. Loizzo Antoine M. Saab Rosa Tundis Federica Menichini Marco Bonesi Vitaliano Piccolo Giancarlo A. Statti Bruno de Cindio Peter J. Houghton Francesco Menichini 2008Journal of Ethnopharmacology2008,,1:1
10In vivo effects of zoledronic acid on peripheral γδ T lymphocytes in early breast cancer patients显示文摘Daniele Santini Federico Martini Maria Elisabetta Fratto Sara Galluzzo Bruno Vincenzi Chiara Agrati Federica Turchi Paola Piacentini Laura Rocci John S. Manavalan Giuseppe Tonini Fabrizio Poccia 2009Cancer Immunology Immunotherapy2009,,1:1
11Solid-phase extraction followed by liquid chromatography- mass spectrometry for trace determination of fi-lactam antibi- otics in bovine milk显示文摘Federica Bruno Roberta Curini Antonio Di Corcia 2001J Agric Food Chem2001,49,:1
12A review of transcriptome studies combined with data mining reveals novel potential markers of malignant pleural mesothelioma显示文摘Ombretta Melaiu Alfonso Cristaudo Erika Melissari Manuela Di Russo Alessandra Bonotti Rossella Bruno Rudy Foddis Federica Gemignani Silvia Pellegrini Stefano Landi 2011Mutation Research-Reviews in Mutation Research2011,,2:1
13Influence of Helicobacter pylori eradication therapy on 13 C aminopyrine breath test: comparison among omeprazole-, lansoprazole-, or pantoprazole-containing regimens显示文摘Edoardo Giannini Paola Romagnoli Alberto Fasoli Bruno Chiarbonello Federica Malfatti Federica Botta Domenico Risso Pasquale B Lantieri Vincenzo Savarino Roberto Testa 2000The American Journal of Gastroenterology2000,,10:1
14Catheter-based Radiofrequency Renal Sympathetic Denervation for Resistant Hypertension显示文摘Bruno Damascelli Gianluigi Patelli Vladimira Tichá Federica Della Rocca Salvatore Lattuada Chiara Sala Alberto Albertoni Andrea D’Alessio Alfonso Funaro Lorenza Scotti 2013Journal of Vascular and Interventional Radiology2013,,:1
15Local search algorithms for political districting显示文摘Federica R Bruno S 2007European journal of operational research2007,,7:1
16Weighted voronoi region algorithms for political districting 显示文摘Federica Ricca Andrea scozzari Bruno Simeone 2008Mathematical and computer modelling2008,,5:1
17Role of capsule endoscopy in suspected celiac disease: A European multi-centre study显示文摘AIM To analyze the diagnostic yield(DY), therapeutic impact(TI) and safety of capsule endoscopy(CE).METHODS This is a multi-centre, observational, analytical, retrospective study. A total of 163 patients with suspicion of celiac disease(CD)(mean age = 46.4 ± 17.3 years, 68.1% women) who underwent CE from 2003 to 2015 were included. Patients were divided into four groups: seronegative CD with atrophy(Group-Ⅰ, n = 19), seropositive CD without atrophy(Group-Ⅱ, n = 39), contraindication to gastroscopy(Group-Ⅲ, n = 6), seronegative CD without atrophy, but with a compatible context(Group-Ⅳ, n = 99). DY, TI and the safety of CE were analysed.RESULTS The overall DY was 54% and the final diagnosis was villous atrophy(n = 65, 39.9%), complicated CD(n = 12, 7.4%) and other enteropathies(n = 11, 6.8%; 8 Crohn's). DY for groups Ⅰ to Ⅳ was 73.7%, 69.2%, 50% and 44.4%, respectively. Atrophy was located in duodenum in 24 cases(36.9%), diffuse in 19(29.2%), jejunal in 11(16.9%), and patchy in 10 cases(15.4%). Factors associated with a greater DY were positive serology(68.3% vs 49.2%, P = 0.034) and older age(P = 0.008). On the other hand, neither sex nor clinical presentation, family background, positive histology or HLA status were associated with DY. CE resultschanged the therapeutic approach in 71.8% of the cases. Atrophy was associated with a greater TI(92.3% vs 45.3%, P < 0.001) and 81.9% of the patients responded to diet. There was one case of capsule retention(0.6%). Agreement between CE findings and subsequent histology was 100% for diagnosing normal/other conditions, 70% for suspected CD and 50% for complicated CD.CONCLUSION CE has a high DY in cases of suspicion of CD and it leads to changes in the clinical course of the disease. CE is safe procedure with a high degree of concordance with histology and it helps in the differential diagnosis of CD.Marisol Luján-Sanchis Enrique Pérez-Cuadrado-Robles Javier Garcia-Lledo José-Francisco Juanmartinena Fernandez Luca Elli Victoria-Alejandra Jiménez-García Juan Egea-Valenzuela Julio Valle-Munoz Cristina Carretero-Ribón Ignacio Fernández-Urién-Sainz Antonio López-Higueras Noelia Alonso-Lazaro Mileidis Sanjuan-Acosta Francisco Sanchez-Ceballos Bruno Rosa Santiago González-Vázquez Federica Branchi Lucía Ruano-Díaz César Prieto-de-Frías Vicente Pons-Beltrán Pilar Borque-Barrera Begona González-Suárez Sofía Xavier Federico Argüelles-Arias Juan-Manuel Herrerías-Gutiérrez Enrique Pérez-Cuadrado-Martínez Javier Sempere-García-Argüelles 2017World Journal of Gastroenterology2017,23,4:0
18Physical exercise and synaptic protection in human and pre-clinical models of multiple sclerosis显示文摘In multiple sclerosis,only immunomodulato ry and immunosuppressive drugs are recognized as disease-modifying therapies.Howeve r,in recent years,several data from pre-clinical and clinical studies suggested a possible role of physical exe rcise as disease-modifying therapy in multiple sclerosis.Current evidence is sparse and often conflicting,and the mechanisms underlying the neuroprotective and antinflammatory role of exercise in multiple sclerosis have not been fully elucidated.Data,mainly derived from pre-clinical studies,suggest that exe rcise could enhance longterm potentiation and thus neuroplasticity,could reduce neuroinflammation and synaptopathy,and dampen astrogliosis and microgliosis.In humans,most trials focused on direct clinical and MRI outcomes,as investigating synaptic,neuroinflammato ry,and pathological changes is not straightfo rward compared to animal models.The present review analyzed current evidence and limitations in research concerning the potential disease-modifying therapy effects of exercise in multiple sclerosis in animal models and human studies.Federica Azzolini Ettore Dolcetti Antonio Bruno Valentina Rovella Diego Centonze Fabio Buttari 2024Neural Regeneration Research2024,19,8:0
19Leptomeningeal metastases from non-small cell lung cancer:state of the art and recent advances显示文摘Patients with leptomeningeal metastases(LM)from non-small cell lung cancer(NSCLC)have a poor outcome with survival of less than 1 year regardless of advancements in treatment strategy.In the past,some randomized clinical trials have been conducted with heterogeneous inclusion criteria,diagnostic parameters,response evaluation and primary endpoints.Efforts to develop a standardized magnetic resonance imaging(MRI)assessment and liquid biopsy techniques to monitor disease evolution in plasma or cerebrospinal fluid(CSF)are underway.This review aims to cover the main clinical and diagnostic challenges of LM from NSCLC,in particular the role of MRI,CSF cytology and liquid biopsy for the diagnosis and monitoring of the disease,as well as the most recent clinical trials on targeted therapies.Targeted therapy,such as epidermal growth factor receptor tyrosine kinase inhibitors and anaplastic lymphoma kinase rearranged inhibitors,represent a feasible treatment with encouraging results in terms of disease control and survival.For ineligible patients,immune checkpoint inhibitors could represent a therapeutic option with acceptable tolerance,although clinical trials focused on LM from NSCLC are lacking and represent a research focus for the future.Alessia Pellerino Valeria Internò Erminia Muscolino Francesca Mo Francesco Bruno Edoardo Pronello Federica Franchino Riccardo Soffietti Roberta Rudà 2020Journal of Cancer Metastasis and Treatment2020,6,1:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费